Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).

ABSTRACT:

SUBMITTER: Bertoli S 

PROVIDER: S-EPMC12485338 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature